Utama › Penyakit Autoimun › North Carolina › Durham
Kajian klinikal Penyakit Autoimun di Durham, NC
15 kajian untuk Penyakit Autoimun sedang mencari peserta di lokasi dalam dan sekitar Durham (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Environmental Risk Factors for the Anti-synthetase Syndrome
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- NIEHS Clinical Research Unit (CRU), Research Triangle Park · 7 mi jauh
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Mengambil pesertaFasa 3
- Duke University Hospital, Durham
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Mengambil pesertaFasa 2/3
- Duke University Medical Center - Accepting Young Adults and Juvenile Patients, Durham
- University of North Carolina at Chapel Hill - Accepting Adult Patients, Chapel Hill · 10 mi jauh
Daratumumab in Primary Antiphospholipid Syndrome
Mengambil pesertaFasa 1/2
- Duke University, Durham
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Mengambil pesertaFasa 1
- Duke University Medical Center, Durham
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Mengambil pesertaFasa 3
- Duke University Hospital, Durham
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Mengambil pesertaFasa 3
- GSK Investigational Site, Durham
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
Mengambil pesertaFasa 1/2
- UNC Chapel Hill, Chapel Hill · 10 mi jauh
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Mengambil pesertaFasa 2/3
- Duke University, Durham
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
Mengambil pesertaFasa 3
- Duke University Medical Center, Durham
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Mengambil pesertaFasa 3
- Site Number - 1013, Durham
- Site Number - 1020, Chapel Hill · 10 mi jauh
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Mengambil pesertaFasa 1
- Duke University, Durham
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Mengambil pesertaKajian pemerhatian
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi jauh
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Mengambil pesertaFasa 1
- Duke University Health System, Durham
Maternal Autoimmune Disease Research Alliance (MADRA) Registry
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Duke University, Durham
Kajian Penyakit Autoimun di bandar lain
- Houston, TX21 kajian
- Washington, DC19 kajian
- New York City, NY19 kajian
- Philadelphia, PA16 kajian
- Boston, MA13 kajian
- Los Angeles, CA12 kajian
- Chicago, IL12 kajian
- Dallas, TX9 kajian
- Cleveland, OH8 kajian
- Atlanta, GA8 kajian
- Milwaukee, WI8 kajian
- Portland, OR8 kajian
Kajian lain di Durham
- Kanser Payudara63 kajian
- Kanser (semua jenis)58 kajian
- Kanser Paru-paru Bukan Sel Kecil39 kajian
- Mieloma Pelbagai37 kajian
- Kanser Metastatik33 kajian
- Leukemia Mieloid Akut33 kajian
- Kanser Paru-paru32 kajian
- Kanser Prostat32 kajian
- Kanser Kolorektal28 kajian
- Leukemia Limfositik Kronik27 kajian
- Kanser Ovari27 kajian
- Kegagalan Jantung26 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.